We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
-9.77%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$1.02B
AUM Growth
-$178M
Cap. Flow
-$36.8M
Cap. Flow %
-3.59%
Top 10 Hldgs %
88.69%
Holding
24
New
4
Increased
–
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$94.9M
2
NEM icon
Newmont
NEM
+$20.5M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$882K
4
DSEY
Diversey Holdings, Ltd. Ordinary Shares
DSEY
+$413K

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$52.8M
2
SJR
Shaw Communications Inc.
SJR
+$49.4M
3
AUY
Yamana Gold, Inc.
AUY
+$33.9M
4
BALY icon
Bally's
BALY
+$17.4M

Sector Composition

Rank Sector Weight
1 Materials 41.27%
2 Healthcare 33.66%
3 Financials 18.3%
4 Technology 4.8%
5 Real Estate 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
1
Bausch Health
BHC
$1.68B
$212M 20.65%
26,439,035
– –
AAMI
2
Acadian Asset Management
AAMI
$2.84B
$188M 18.3%
8,950,121
– –
PPTA
3
Perpetua Resources
PPTA
$2.1B
$90.9M 8.88%
24,771,542
– –
NG icon
4
NovaGold Resources
NG
$2.5B
$88.7M 8.66%
22,226,300
– –
MDGL icon
5
Madrigal Pharmaceuticals
MDGL
$12.4B
$80.9M 7.9%
+350,200
New +$94.9M
AU icon
6
AngloGold Ashanti
AU
$38.8B
$80.8M 7.89%
3,833,492
– –
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$51.4M 5.02%
500,000
-500,000
-50% -$52.8M
THRY icon
8
Thryv Holdings
THRY
$188M
$49.2M 4.8%
2,000,000
– –
AEM icon
9
Agnico Eagle Mines
AEM
$70.1B
$39.2M 3.82%
783,561
– –
SSRM icon
10
SSR Mining
SSRM
$5.05B
$28.4M 2.77%
2,000,000
– –
THM
11
International Tower Hill Mines
THM
$481M
$25.7M 2.51%
61,930,724
– –
SA
12
Seabridge Gold
SA
$2.64B
$24.9M 2.44%
2,070,000
– –
NEM icon
13
Newmont
NEM
$94.5B
$19.3M 1.88%
+452,000
New +$20.5M
EQX icon
14
Equinox Gold
EQX
$6.9B
$11.4M 1.12%
2,500,000
– –
TMQ
15
Trilogy Metals
TMQ
$511M
$8.5M 0.83%
14,326,996
– –
NMRK icon
16
Newmark Group
NMRK
$2.82B
$7.99M 0.78%
1,284,625
– –
TELL
17
DELISTED
Tellurian Inc.
TELL
$7.53M 0.74%
5,340,663
– –
IAG icon
18
IAMGOLD
IAG
$7.99B
$4.87M 0.48%
1,850,000
– –
BABA icon
19
Alibaba
BABA
$275B
$4.17M 0.41%
50,000
– –
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$984K 0.1%
+25,000
New +$882K
DSEY
21
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$420K 0.04%
+50,000
New +$413K
BALY icon
22
Bally's
BALY
$720M
– –
-891,852
Closed -$17.4M
SJR
23
DELISTED
Shaw Communications Inc.
SJR
– –
-1,650,000
Closed -$49.4M
AUY
24
DELISTED
Yamana Gold, Inc.
AUY
– –
-5,801,500
Closed -$33.9M

Similar funds

TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Paulson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Paulson & Co held 24 positions worth $1.02B, down 15% from $1.2B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Paulson & Co withdrew a net $36.8M in Q2 2023, closing 3 positions and reducing 1 holding. Its most notable exit was Shaw Communications Inc., an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Materials at 41% of assets, down from 42% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Paulson & Co opened a new position in Madrigal Pharmaceuticals worth $80.9M.

  • Paulson & Co's largest Q2 2023 buy was Madrigal Pharmaceuticals: 350,200 shares worth $80.9M.
  • Paulson & Co's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $52.8M.
  • Paulson & Co fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $49.4M.
  • Paulson & Co's ten largest holdings make up 89% of its $1.02B portfolio in Q2 2023.
  • Paulson & Co opened 4 new positions and closed 3 in Q2 2023.
  • Paulson & Co's portfolio value fell 15% quarter-over-quarter to $1.02B.

Based on Paulson & Co's 13F filing for Q2 2023, filed 14 Aug 2023.